NeuroSense Therapeutics Ltd. — SC 13G/A Filings
5 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by NeuroSense Therapeutics Ltd. (NRSNW), sorted by most recent first. Each row links to the full filing on EdgarLookup. NeuroSense Therapeutics Ltd. has filed 5 SC 13G/A documents with the SEC since 2021. To view all SEC filings by NeuroSense Therapeutics Ltd., see the full filings list.
All
20-F
3
424B3
424B4
424B5
6-K
6-K/A
8-A12B
AW
CERT
CORRESP
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
FWP
POS AM
POS EX
S-8
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-24-013046 | Feb 13, 2024 | — |
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-24-012931 | Feb 13, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-23-027346 | Apr 5, 2023 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-23-020281 | Mar 15, 2023 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-23-020278 | Mar 15, 2023 | — |